Regulation of TNFα and interleukin-10 production by prostaglandins I2 and E2:: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists

被引:139
作者
Shinomiya, S
Naraba, H
Ueno, A
Utsunomiya, I
Maruyama, T
Ohuchida, S
Ushikubi, F
Yuki, K
Narumiya, S
Sugimoto, Y
Ichikawa, A
Oh-ishi, S
机构
[1] Kitasato Inst, Minato Ku, Tokyo 1088642, Japan
[2] Kitasato Univ, Sch Pharmaceut Sci, Dept Pharmacol, Minato Ku, Tokyo 1088641, Japan
[3] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan
[4] Asahikawa Med Coll, Dept Pharmacol, Asahikawa, Hokkaido 0788510, Japan
[5] Kyoto Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Kyoto 6068501, Japan
[6] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan
[7] Kitasato Inst, Minato Ku, Tokyo 1088642, Japan
关键词
LP receptor; EP2; receptor; EP4; TNF alpha; IL-10; zymosan;
D O I
10.1016/S0006-2952(01)00586-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To know which receptors of prostaglandins are involved in the regulation of TNF alpha and interleukin 10 (IL-10) production, we examined the production of these cytokines in murine peritoneal macrophages stimulated with zymosan. The presence of PGE, or the PGI, analog carbacyclin in the medium reduced the TNF alpha production to one-half, whereas IL-10 production increased several fold; and indomethacin caused the reverse effects, suggesting that endogenous prostaglandins may have a regulatory effect on the cytokine production. Among prostaglandin E (EP) receptor-selective synthetic agonists, EP2 and EP4 agonists caused down-regulation of the zymosan-induced TNF alpha production, but up-regulation on the IL-IO production; while EP1 and EP3 agonists showed no effect. Macrophages harvested from prostaglandin I (IP) receptor-deficient mice showed the up- and down-regulatory effects on the cytokine production by the EP2 and EP4 agonists or PGE(2), but no effect was obtained by carbacyclin. On the contrary, macrophages from EP2-deficient mice showed the effect by PGE(2), carbacyclin, and the EP4 agonist, but not by the EP2 agonist; and the cells from EP4-deficient mice showed the effect by PGE,, carbacyclin, and EP2 agonist, but not by the EP3 agonist. These functional effects of prostaglandins well accorded with the mRNA expression of TNF alpha and IL-10 when such expression was examined by the RT-PCR method. The peritoneal macrophages from normal mice expressed IF, EP2, and EP4 receptors, but not EPI and EP3, when examined by RT-PCR. Thus the results suggest that PGI, and PGE, generated simultaneously with cytokines by macrophages treated with zymosan may influence the cytokine production through IF, EP2, and EP4 receptors. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1153 / 1160
页数:8
相关论文
共 29 条
[1]   Signaling routes to CREM and CREB: plasticity in transcriptional activation [J].
De Cesare, D ;
Fimia, GM ;
Sassone-Corsi, P .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (07) :281-285
[2]   TRANSCRIPTIONAL REGULATION BY EXTRACELLULAR SIGNALS - MECHANISMS AND SPECIFICITY [J].
HILL, CS ;
TREISMAN, R .
CELL, 1995, 80 (02) :199-211
[3]  
HIRAKI H, 1999, P NATL ACAD SCI USA, V96, P10501
[4]  
KAMBAYASHI T, 1995, J IMMUNOL, V155, P4909
[5]  
KAMBAYASHI T, 1995, J IMMUNOL, V154, P3383
[6]   Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1 [J].
Katsuyama, M ;
Ikegami, R ;
Karahashi, H ;
Amano, F ;
Sugimoto, Y ;
Ichikawa, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 251 (03) :727-731
[7]  
KUNKEL SL, 1988, J BIOL CHEM, V263, P5380
[8]   Concordant induction of prostaglandin E(2) synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E(2) over thromboxane and prostaglandin D-2 in lipopolysaccharide-stimulated rat peritoneal macrophages [J].
Matsumoto, H ;
Naraba, H ;
Murakami, M ;
Kudo, I ;
Yamaki, K ;
Ueno, A ;
Ohishi, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 230 (01) :110-114
[9]   PROSTAGLANDINS, PROSTACYCLIN, AND THROMBOXANES [J].
MCGIFF, JC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1981, 21 :479-509
[10]  
Monaco L, 1997, ADV SEC MESS PHOSPH, V31, P63